2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lymphoma, T-Cell, Peripheral
16
Lymphoma, T-Cell
10
Recurrence
7
Lymphoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Large-Cell, Anaplastic
5
Immunoblastic Lymphadenopathy
4
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Follicular
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Waldenstrom Macroglobulinemia
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Sezary Syndrome
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Burkitt Lymphoma
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Stomach Neoplasms
1
Smoking
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Cyclophosphamide
87
fludarabine
77
fludarabine phosphate
45
Tacrolimus
45
Whole-Body Irradiation
42
Mycophenolic Acid
42
Busulfan
35
Melphalan
32
Antilymphocyte Serum
24
Methotrexate
23
thymoglobulin
22
Standard of Care
22
Rituximab
22
venetoclax
20
Thiotepa
20
Sirolimus
20
Azacitidine
20
Stem Cell Transplantation
18
Granulocyte Colony-Stimulating Factor
18
Practice Guidelines as Topic
17
Cytarabine
16
Bortezomib
16
Nivolumab
15
Filgrastim
15
Specimen Handling
14
Dexamethasone
14
Blood Specimen Collection
14
Cyclosporine
13
Surveys and Questionnaires
12
Mesna
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
10-propargyl-10-deazaaminopterin
×
Clear all
NCT07036133
2026-02-11
SPI-FOL-102
Acrotech Biopharma Inc.
Phase 1
Recruiting
24 enrolled